Monitoring Allergic Patients on Omalizumab with Free and Total Serum IgE Measurements

Affiliations

Editorial

Robert G Hamilton. J Allergy Clin Immunol Pract. 2016 Mar-Apr.

. 2016 Mar-Apr;4(2):366-8.

doi: 10.1016/j.jaip.2015.12.002.

¹ Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: rhamilt2@jhmi.edu.

No abstract available

Comment on

Measuring total IgE is useful in detecting exacerbations in patients with allergic bronchopulmonary aspergillosis receiving omalizumab.
Bobolea I, Fernández Rodriguez C, Diaz-Campos R, Melero-Moreno C, Vives-Conesa R. Bobolea I, et al. J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):361-3. doi: 10.1016/j.jaip.2015.10.020. Epub 2015 Dec 24. J Allergy Clin Immunol Pract. 2016. PMID: 26725156 No abstract available.
Following total IgE concentration in patients with allergic bronchopulmonary aspergillosis on omalizumab.
Kelso JM. Kelso JM. J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):364-5. doi: 10.1016/j.jaip.2015.11.014. Epub 2015 Dec 24. J Allergy Clin Immunol Pract. 2016. PMID: 26725160 No abstract available.